3,193 research outputs found
Observation of the decay mode K_L -> pi^+ pi^- e^+ e^-
We report on results of an experimental search for the K_L -> pi^+ pi^- e^+
e^- decay mode. We found 13.5 +- 4.0 events and determined its branching ratio
to be (4.4 +- 1.3(stat) +- 0.5(syst))*10^{-7}. The result agrees well with the
theoretical prediction.Comment: 9 pages, 6 eps-figures, LaTeX2e, graphicx package, submitted to
Physics Letters
Experimental search for the decay mode K_L -> pi^0 gamma e^+ e^-
We report on results of a search for the decay mode K_L -> pi^0 gamma e^+ e^-
conducted by the E162 experiment at KEK. We observed no events and set a 90%
confidence level upper limit of Br(K_L -> pi^0 gamma e^+ e^-)< 7.1x10^{-7} for
its branching ratio. This is the first published experimental result on this
decay mode.Comment: 10 pages, 4 figures, submitted to Physics Letters
Measurement of tau polarization in e+ e- annihilation at sqrt{s}=58 GeV
The polarization of tau leptons in the reaction e+ e- --> tau+ tau- has been
measured using a e+e- collider, TRISTAN, at the center-of-mass energy of 58
GeV. From the kinematical distributions of daughter particles in tau --> e nu
nu-bar, mu nu nu-bar, rho nu or pi(K) nu decays, the average polarization of
tau- and its forward-backward asymmetry have been evaluated to be 0.012 +-
0.058 and 0.029 +- 0.057, respectively.Comment: 18 pages, 5 figure
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
Background: HAGE protein is a known immunogenic cancer-specific antigen. Methods: The biological, prognostic and predictive values of HAGE expression was studied using immunohistochemistry in three cohorts of patients with BC (n=2147): early primary (EP-BC; n=1676); primary oestrogen receptor-negative (PER-BC; n=275) treated with adjuvant anthracycline-combination therapies (Adjuvant-ACT); and primary locally advanced disease (PLA-BC) who received neo-adjuvant anthracycline-combination therapies (Neo-adjuvant-ACT; n=196). The relationship between HAGE expression and the tumour-infiltrating lymphocytes (TILs) in matched prechemotherapy and postchemotherapy samples were investigated. Results: Eight percent of patients with EP-BC exhibited high HAGE expression (HAGEþ) and was associated with aggressive clinico-pathological features (Ps<0.01). Furthermore, HAGEþexpression was associated with poor prognosis in both univariate and multivariate analysis (Ps<0.001). Patients with HAGE+ did not benefit from hormonal therapy in high-risk ER-positive disease. HAGE+ and TILs were found to be independent predictors for pathological complete response to neoadjuvant-ACT; P<0.001. A statistically significant loss of HAGE expression following neoadjuvant-ACT was found (P=0.000001), and progression-free survival was worse in those patients who had HAGE+ residual disease (P=0.0003). Conclusions: This is the first report to show HAGE to be a potential prognostic marker and a predictor of response to ACT in patients with BC
GEANT4 : a simulation toolkit
Abstract Geant4 is a toolkit for simulating the passage of particles through matter. It includes a complete range of functionality including tracking, geometry, physics models and hits. The physics processes offered cover a comprehensive range, including electromagnetic, hadronic and optical processes, a large set of long-lived particles, materials and elements, over a wide energy range starting, in some cases, from 250 eV and extending in others to the TeV energy range. It has been designed and constructed to expose the physics models utilised, to handle complex geometries, and to enable its easy adaptation for optimal use in different sets of applications. The toolkit is the result of a worldwide collaboration of physicists and software engineers. It has been created exploiting software engineering and object-oriented technology and implemented in the C++ programming language. It has been used in applications in particle physics, nuclear physics, accelerator design, space engineering and medical physics. PACS: 07.05.Tp; 13; 2
System Test of the ATLAS Muon Spectrometer in the H8 Beam at the CERN SPS
An extensive system test of the ATLAS muon spectrometer has been performed in
the H8 beam line at the CERN SPS during the last four years. This spectrometer
will use pressurized Monitored Drift Tube (MDT) chambers and Cathode Strip
Chambers (CSC) for precision tracking, Resistive Plate Chambers (RPCs) for
triggering in the barrel and Thin Gap Chambers (TGCs) for triggering in the
end-cap region. The test set-up emulates one projective tower of the barrel
(six MDT chambers and six RPCs) and one end-cap octant (six MDT chambers, A CSC
and three TGCs). The barrel and end-cap stands have also been equipped with
optical alignment systems, aiming at a relative positioning of the precision
chambers in each tower to 30-40 micrometers. In addition to the performance of
the detectors and the alignment scheme, many other systems aspects of the ATLAS
muon spectrometer have been tested and validated with this setup, such as the
mechanical detector integration and installation, the detector control system,
the data acquisition, high level trigger software and off-line event
reconstruction. Measurements with muon energies ranging from 20 to 300 GeV have
allowed measuring the trigger and tracking performance of this set-up, in a
configuration very similar to the final spectrometer. A special bunched muon
beam with 25 ns bunch spacing, emulating the LHC bunch structure, has been used
to study the timing resolution and bunch identification performance of the
trigger chambers. The ATLAS first-level trigger chain has been operated with
muon trigger signals for the first time
Measurement of the cross-section and charge asymmetry of bosons produced in proton-proton collisions at TeV with the ATLAS detector
This paper presents measurements of the and cross-sections and the associated charge asymmetry as a
function of the absolute pseudorapidity of the decay muon. The data were
collected in proton--proton collisions at a centre-of-mass energy of 8 TeV with
the ATLAS experiment at the LHC and correspond to a total integrated luminosity
of 20.2~\mbox{fb^{-1}}. The precision of the cross-section measurements
varies between 0.8% to 1.5% as a function of the pseudorapidity, excluding the
1.9% uncertainty on the integrated luminosity. The charge asymmetry is measured
with an uncertainty between 0.002 and 0.003. The results are compared with
predictions based on next-to-next-to-leading-order calculations with various
parton distribution functions and have the sensitivity to discriminate between
them.Comment: 38 pages in total, author list starting page 22, 5 figures, 4 tables,
submitted to EPJC. All figures including auxiliary figures are available at
https://atlas.web.cern.ch/Atlas/GROUPS/PHYSICS/PAPERS/STDM-2017-13
- …